10 More of 50 Fairly-Valued Dividend Growth Stocks Offering Moderately High Yields: Part 2

Introduction This is the second of a five-part series presenting 50 dividend growth stocks that I have screened for current fair value.  With this article I will be covering 10 additional dividend growth research candidates in addition to the initial 10 that I presented in part 1 found here. Furthermore, I wanted to be clear Read more about 10 More of 50 Fairly-Valued Dividend Growth Stocks Offering Moderately High Yields: Part 2[…]

Finding Value In The S&P 500: 9 Healthcare Dividend Growth Stocks: Part 1

Introduction

Most everyone would agree that the stock market as measured by the S&P 500 is not cheap today.  However, there might be a great deal of disagreement regarding precisely how overvalued the S&P 500 currently is.  Nevertheless, I would agree that in the general sense, stocks are not exactly bargains today.  This might especially be true regarding best-of-breed blue-chip dividend growth stocks.  Low interest rates have enhanced the attraction for high-quality dividend paying stocks.

[…]

5 Attractive Biotechnology Stocks for Healthy Long-term Returns

Introduction

I am a fervent believer that investors are best served by investing towards a specific investment objective that suits their own unique goals, objectives and risk tolerance.  In other words, investing is not always trying to get the highest possible total returns.  If that were true, no one would have ever invested in bonds, CDs or other fixed income instruments.

[…]

10 Undervalued Dividend Champions For 2016: Be Greedy When Others Are Fearful

Introduction

Dividend Champions/Aristocrats are the go-to dividend paying stocks for prudent investors desirous of a safe, predictable and growing stream of income on the common stock portion of their retirement portfolios.  As most investors are aware, in order to be classified as a Dividend Champion/Aristocrat a company must meet the stern test of consecutively increasing their dividend for 25 years or longer.  Of all the dividend paying stocks in the universe, only a select few make these prestigious lists. […]

10 Undervalued Dividend Champions for 2016: Be Greedy When Others Are Fearful

Introduction

Dividend Champions/Aristocrats are the go-to dividend paying stocks for prudent investors desirous of a safe, predictable and growing stream of income on the common stock portion of their retirement portfolios. As most investors are aware, in order to be classified as a Dividend Champion/Aristocrat, a company must meet the stern test of consecutively increasing their dividend for 25 years or longer. Of all the dividend paying stocks in the universe, only a select few make these prestigious lists.

[…]

11 Dividend Aristocrats That Have Come Into Fair Value

Introduction Recent weakness in the stock market is creating value for those with the foresight and courage to invest when opportunities present themselves.  This is important, because subsequent to the Great Recession many of the premier dividend growth stocks such as those on the Standard & Poor’s Dividend Aristocrats list have become overvalued. Many attribute Read more about 11 Dividend Aristocrats That Have Come Into Fair Value[…]

The Best Way to Judge Past Performance: Part Two

Introduction

On virtually every financial website on the planet there is a never-ending daily stream of stock tips and recommendations.  Consequently, the investing public is literally flooded with information and advice regarding what stock to buy today or not to buy.  Some of what is offered is supported by factual information and logic, but unfortunately, much of what is offered is merely based on the opinion of the author.  This presents quite a challenge to the prudent prospective investor seeking sound advice or guidance.  The recommendations are presented and it is left up to the individual to act on the advice or not based on the content as written. […]

Mr. Valuation Thinks AbbVie Will ‘Humira’ Us For A Few More Years

Introduction It is not enough to simply identify a great company to invest in. Before investing in any common stock, it is critically important to evaluate and understand the valuation that the market is currently valuing it at. If valuation is too high, you are exposing your money to higher risk while simultaneously reducing your Read more about Mr. Valuation Thinks AbbVie Will ‘Humira’ Us For A Few More Years[…]